收藏切换
Mechanism of action and clinical application progress of LIV-1 protein-targeted drugs in breast cancer
收藏切换
Yangyang LI1, Xianglin LIU2, Hengyu LI1, *
World Clinical Drug | 2026, 47(5) : 582 - 588
Less
收藏切换
World Clinical Drug | 2026, 47(5): 582-588
• Review •
Mechanism of action and clinical application progress of LIV-1 protein-targeted drugs in breast cancer
Full
Yangyang LI1, Xianglin LIU2, Hengyu LI1, *
Affiliations
  • 1.Department of Breast and Thyroid Surgery, Changhai Hospital, Naval Military Medical University, Shanghai 200433, China
  • 2.Department of General Surgery, The 921st Hospital of the Joint Logistics Support Force of The Chinese People's Liberation Army, Changsha 410003, Hunan Province, China
Published: 2026-05-10 doi: 10.13683/j.wph.2026.05.019
Outline
收藏切换

The zinc ion transporter LIV-1 protein (also known as SLC39A6, ZIP6) is localized on the cell membrane and contains multiple histidine-rich transmembrane domains. It participates in regulating the occurrence, development,invasion, metastasis, and epithelial-mesenchymal transition pathway of breast cancer, holding value as both a diagnostic marker and a potential therapeutic target in multiple cancers. With the breakthrough of antibody-drug conjugates in targeted therapy for breast cancer, the development and clinical application of LIV-1 protein-targeted drugs have become a new hotspot. This article reviews the research progress and therapeutic translational value of LIV-1 protein-targeted drugs in breast cancer and other malignancies from the perspectives of structure-activity relationship, pathological mechanisms,and tumor microenvironment regulation, aiming to provide a theoretical basis for innovating treatment strategies for related diseases.

LIV-1 protein  /  targeted drugs  /  zinc ion transporter  /  breast cancer  /  antibody-drug conjugates
李洋洋, 刘湘林, 李恒宇. LIV-1 蛋白靶向药物对乳腺癌的作用机制及其临床应用. 世界临床药物, 2026 , 47 (5) : 582 -588 . DOI: 10.13683/j.wph.2026.05.019
Yangyang LI, Xianglin LIU, Hengyu LI. Mechanism of action and clinical application progress of LIV-1 protein-targeted drugs in breast cancer[J]. World Clinical Drug, 2026 , 47 (5) : 582 -588 . DOI: 10.13683/j.wph.2026.05.019
Year 2026 volume 47 Issue 5
51
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.05.019
  • Receive Date:2025-12-20
  • Online Date:2026-11-05
  • Published:2026-05-10
Article Data
Affiliations
History
  • Received:2025-12-20
Affiliations
    1.Department of Breast and Thyroid Surgery, Changhai Hospital, Naval Military Medical University, Shanghai 200433, China
    2.Department of General Surgery, The 921st Hospital of the Joint Logistics Support Force of The Chinese People's Liberation Army, Changsha 410003, Hunan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.05.019
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT